SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
July 10, 2025
 · 
6 min read
Press Releases
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
June 26, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy
June 24, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung
June 3, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
May 28, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 20, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Reports First Quarter 2025 Results
May 15, 2025
 · 
9 min read
Press Releases
Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer
May 8, 2025
 · 
5 min read
Press Releases
bioAffinity Technologies Announces Pricing of $3.25 Million Offering
May 7, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
April 17, 2025
 · 
6 min read
Load More
JOBS